01 1Hana Pharmaceutical Co., Ltd.
01 1Hana Pharmaceutical Co., Ltd.
01 1Flacainide acetate
01 1South Korea
Registrant Name : Hana Pharmaceutical Co., Ltd.
Registration Date : 2021-03-23
Registration Number : 20210323-211-J-896
Manufacturer Name : Hana Pharmaceutical Co., Ltd...
Manufacturer Address : 133, Jeyakgongdan 3-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
48
PharmaCompass offers a list of Flecainide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Flecainide manufacturer or Flecainide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flecainide manufacturer or Flecainide supplier.
A Apocard manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apocard, including repackagers and relabelers. The FDA regulates Apocard manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apocard API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Apocard manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Apocard supplier is an individual or a company that provides Apocard active pharmaceutical ingredient (API) or Apocard finished formulations upon request. The Apocard suppliers may include Apocard API manufacturers, exporters, distributors and traders.
click here to find a list of Apocard suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Apocard Drug Master File in Korea (Apocard KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Apocard. The MFDS reviews the Apocard KDMF as part of the drug registration process and uses the information provided in the Apocard KDMF to evaluate the safety and efficacy of the drug.
After submitting a Apocard KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Apocard API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Apocard suppliers with KDMF on PharmaCompass.
